| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/10/2001 | WO2001033191A1 Cytological imaging system and method |
| 05/10/2001 | WO2001033188A2 Assay method for determining product r's effect on adenovirus infection of hela cells |
| 05/10/2001 | WO2001033187A2 Enzymatic cycling assays for homocysteine and cystathionine |
| 05/10/2001 | WO2001032935A2 Molecular microarrays and methods for production and use thereof |
| 05/10/2001 | WO2001032933A1 Assay method for determining product r's effect on induction of ifn-gamma in cultured cells |
| 05/10/2001 | WO2001032932A2 Method of identifying a nucleic acid sequence |
| 05/10/2001 | WO2001032931A2 Method and compositions for selectively inhibiting amplification of sequences in a population of nucleic acid molecules |
| 05/10/2001 | WO2001032930A1 Methods and apparatuses for analyzing polynucleotide sequences |
| 05/10/2001 | WO2001032929A1 Methods and compositions for analysis of snps and strs |
| 05/10/2001 | WO2001032928A2 Methods of determining individual hypersensitivity to an agent |
| 05/10/2001 | WO2001032927A2 Tissue specific genes of diagnostic import |
| 05/10/2001 | WO2001032926A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 05/10/2001 | WO2001032925A1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 05/10/2001 | WO2001032924A1 Compositions and methods of synthesis and use of novel nucleic acid structures |
| 05/10/2001 | WO2001032922A2 Methods for detection of a target nucleic acid sequence |
| 05/10/2001 | WO2001032921A2 Method of diagnosing rheumatoid arthritis |
| 05/10/2001 | WO2001032920A2 Agents implicated in endometriosis |
| 05/10/2001 | WO2001032919A2 Group of novel primer pairs for pcr amplification, primer pairs, gene probes and method for detecting technically genetically modified plant material |
| 05/10/2001 | WO2001032917A1 Method of cell sedimentation using precision deposit manifold |
| 05/10/2001 | WO2001032916A2 Automated lysophospholipid assay and methods of detecting cancer |
| 05/10/2001 | WO2001032915A2 Reversed-phase hplc assay for plasminogen activators |
| 05/10/2001 | WO2001032912A1 Use of the jak-stat system in cultured cells to trace effects of tested compounds |
| 05/10/2001 | WO2001032911A2 Toxicity assay using pva-immobilised luminescent bacteria |
| 05/10/2001 | WO2001032910A2 27 human secreted proteins |
| 05/10/2001 | WO2001032909A2 Method of detecting the presence or absence of specific genes |
| 05/10/2001 | WO2001032891A2 Human lipase |
| 05/10/2001 | WO2001032888A2 Human transferase molecules |
| 05/10/2001 | WO2001032887A1 Compositions and methods utilizing dna polymerases |
| 05/10/2001 | WO2001032885A2 Human lipase |
| 05/10/2001 | WO2001032882A2 Nucleic acids and proteins from group b streptococcus |
| 05/10/2001 | WO2001032877A2 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 05/10/2001 | WO2001032876A2 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 05/10/2001 | WO2001032865A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 05/10/2001 | WO2001032864A2 Gpcr-kd5 polypeptides and dna sequences thereof |
| 05/10/2001 | WO2001032858A1 A high throughput screening (hts) method |
| 05/10/2001 | WO2001032849A2 Inhibitors of vegetable cystathionin gamma synthase |
| 05/10/2001 | WO2001032845A2 Methods for the preparation of (lipo)peptide synthetases and (lipo)peptides produced therewith |
| 05/10/2001 | WO2001032837A1 19 human secreted proteins |
| 05/10/2001 | WO2001032831A2 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 05/10/2001 | WO2001032828A2 Biological fluid processing |
| 05/10/2001 | WO2001032802A1 Method and apparatus for predicting male infertility |
| 05/10/2001 | WO2001032783A1 Water-soluble rhodamine dyes and conjugates thereof |
| 05/10/2001 | WO2001032710A1 Dog and rabbit motilin receptor orthologs |
| 05/10/2001 | WO2001032704A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 05/10/2001 | WO2001032703A1 Substance capable of controlling the inclusion of exon 10 of the tau gene, and its therapeutic use against tauopathies |
| 05/10/2001 | WO2001032702A2 Molecular structure of rhd negative locus |
| 05/10/2001 | WO2001032696A2 Traf family proteins |
| 05/10/2001 | WO2001032687A1 10 human secreted proteins |
| 05/10/2001 | WO2001032685A2 Gene expression directed by a super-psa promoter |
| 05/10/2001 | WO2001032675A1 32 human secreted proteins |
| 05/10/2001 | WO2001032674A1 26 human secreted proteins |
| 05/10/2001 | WO2001032673A1 Sequences encoding human neoplastic marker |
| 05/10/2001 | WO2001032672A1 Preparation of nucleic acid samples |
| 05/10/2001 | WO2001032614A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 05/10/2001 | WO2001032209A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/10/2001 | WO2001032206A1 Detection of viral pathology mediated by lymphocytes |
| 05/10/2001 | WO2001032186A2 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
| 05/10/2001 | WO2001032156A2 Methods for treating fibroproliferative diseases |
| 05/10/2001 | WO2001032015A1 Use of haploid genomes for genetic diagnosis, modification and multiplication |
| 05/10/2001 | WO2001021804B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/10/2001 | WO2001016304A3 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing |
| 05/10/2001 | WO2001005800A3 A method for the enrichment of heteroduplexes and its use in mutation detection |
| 05/10/2001 | WO2001000869A3 Arrays of catalytic or pre-catalytic nucleic acids |
| 05/10/2001 | WO2000078943A3 EXPANSION OF A NOVEL CAG TRINUCLEOTIDE REPEAT IN THE 5' REGION OF THE PROTEIN PHOSPHATASE 2A PPP2R2Bβ GENE IS ASSOCIATED WITH SCA12 |
| 05/10/2001 | WO2000077243A3 CoRT-PCR ASSAY FOR THE DISCRIMINATION OF ENDOGENOUS REVERSE TRANSCRIPTASE ACTIVITY IN EUKARYOTIC CELL LINES FROM INFECTIOUS RETROVIRUS CONTAMINATION |
| 05/10/2001 | WO2000077207A3 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 05/10/2001 | WO2000077035A3 Novel potassium channels and genes encoding these potassium channels |
| 05/10/2001 | WO2000072666A3 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE |
| 05/10/2001 | WO2000063435A8 Method of identifying toxic agents using differential gene expression |
| 05/10/2001 | WO2000061802A3 Method and kitset for sampling and storage of biological samples |
| 05/10/2001 | WO2000034334A9 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
| 05/10/2001 | WO2000032824A3 Length determination of nucleic acid repeat sequences by discontinuous primer extension |
| 05/10/2001 | US20010001063 Detecting presence of target nucleic acid sequence in sample by contacting sample, under conditions permitting primer-initiated nucleic acid amplification and catalytic nucleic acid activity, with DNA primer and zymogene |
| 05/10/2001 | US20010001062 Screening methods for presqualene diphosphate analogs |
| 05/10/2001 | DE19953519A1 Inhibitoren der pflanzlichen Cystathionin gamma-Synthase Inhibitors of plant cystathionine gamma-synthase |
| 05/10/2001 | DE19952960A1 Verfahren zur Identifizierung von anti-apoptotisch wirksamen Verbindungen A method of identifying anti-apoptotically active compounds |
| 05/10/2001 | DE19952723A1 Vorrichtung und Verfahren zur Hybridisierung doppelsträngiger DNA-Proben an Oligomer-Arrays Apparatus and method for hybridizing double-stranded DNA samples to oligomer arrays |
| 05/10/2001 | DE19950969A1 Doppelstrang-Nukleinsäure-Sonden und deren Verwendung Double-stranded nucleic acid probes and their use |
| 05/10/2001 | DE19943913A1 Predicting resistance to ethambutol in mycobacteria, useful for selection of treatment, by detecting specific mutation in the embB resistance gene |
| 05/10/2001 | DE19943911A1 Predicting resistance to isoniazide in mycobacteria, useful for selection of treatment, by detecting specific mutation in the katG resistance gene |
| 05/10/2001 | CA2390387A1 Method of diagnosing rheumatoid arthritis |
| 05/10/2001 | CA2390305A1 Methods for cancer prognosis and diagnosis |
| 05/10/2001 | CA2390180A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 05/10/2001 | CA2389964A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/10/2001 | CA2389832A1 Improved automated lpa assay and methods of detecting cancer |
| 05/10/2001 | CA2389769A1 Molecular microarrays and methods for production and use thereof |
| 05/10/2001 | CA2389765A1 Cpg receptor (cpg-r) and methods relating thereto |
| 05/10/2001 | CA2389754A1 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 05/10/2001 | CA2389751A1 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 05/10/2001 | CA2389676A1 Substance capable of controlling the inclusion of exon 10 of the tau gene, and its therapeutic use against tauopathies |
| 05/10/2001 | CA2389672A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 05/10/2001 | CA2389575A1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 05/10/2001 | CA2389415A1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 05/10/2001 | CA2389335A1 Gene expression directed by a super-psa promoter |
| 05/10/2001 | CA2389329A1 Dog and rabbit motilin receptor orthologs |
| 05/10/2001 | CA2389228A1 Biological fluid processing |
| 05/10/2001 | CA2388822A1 27 human secreted proteins |
| 05/10/2001 | CA2388619A1 Method and compositions for selectively inhibiting amplification of sequences in a population of nucleic acid molecules |
| 05/10/2001 | CA2388612A1 Sequences encoding human neoplastic marker |
| 05/10/2001 | CA2388553A1 Methods for detection of a target nucleic acid sequence |